[Management of refractory thyroid cancers]. [electronic resource]
Producer: 20110914Description: 149-57 p. digitalISSN:- 2213-3941
- Angiogenesis Inhibitors -- therapeutic use
- Carcinoma -- drug therapy
- Carcinoma, Papillary
- Humans
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Protein Kinase Inhibitors -- adverse effects
- Randomized Controlled Trials as Topic
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Thyroid Cancer, Papillary
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.